Drug Shortage Report for PULMICORT TURBUHALER
Report ID | 152520 |
Drug Identification Number | 00852074 |
Brand name | PULMICORT TURBUHALER |
Common or Proper name | budesonide |
Company Name | ASTRAZENECA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 100MCG |
Dosage form(s) | POWDER (METERED DOSE) |
Route of administration | INHALATION INHALATION |
Packaging size | 200 inhalations |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-01-21 |
Actual start date | 2022-01-21 |
Estimated end date | 2022-01-31 |
Actual end date | 2022-02-01 |
Shortage status | Resolved |
Updated date | 2022-02-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-02-02 | English | Compare |
v7 | 2022-02-01 | French | Compare |
v6 | 2022-02-01 | English | Compare |
v5 | 2022-01-22 | English | Compare |
v4 | 2022-01-21 | French | Compare |
v3 | 2022-01-21 | English | Compare |
v2 | 2022-01-12 | French | Compare |
v1 | 2022-01-12 | English | Compare |
Showing 1 to 8 of 8